Amrapali Capital and Finance Services Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 9, 2025, 12:19 pm

Quick Insight

Amrapali Capital and Finance Services Ltd, an NBFC, currently trades at a price of ₹20.0 with a market capitalization of ₹19.6 Cr and a P/E ratio of 17.0. The company's return on equity (ROE) stands at 1.38%, while return on capital employed (ROCE) is at 3.33%. Notably, the company's operating profit margin (OPM) is at 0.34%, and it has a price-to-book value (P/BV) ratio of 0.21x. With 64.66% of ownership held by promoters and a sizeable reserve of ₹74.08 Cr, Amrapali Capital demonstrates stability and strong promoter backing. However, the low ROE and ROCE figures indicate potential inefficiencies in capital utilization compared to sector averages. Additionally, the high number of shareholders (64) could lead to governance challenges and decision-making complexities.

One key strength of Amrapali Capital lies in its relatively low borrowings of ₹22.06 Cr, indicating a conservative leverage position. Furthermore, the interest coverage ratio (ICR) of 1.62x suggests the company can comfortably meet its interest obligations. However, the company's cash conversion cycle (CCC) of 381.25 days appears excessively high, potentially pointing to inefficiencies in working capital management. Looking ahead, Amrapali Capital's outlook could improve by enhancing operational efficiency to boost ROE and ROCE figures, streamlining its shareholder base, and actively managing its CCC to release trapped cash flows. Conversely, a worsening outlook could result from a failure to address these operational inefficiencies, leading to decreased investor confidence and potential liquidity challenges. In conclusion, while Amrapali Capital shows promise with its strong promoter holding and conservative leverage, addressing operational metrics will be crucial for sustained growth and value creation.

Competitors of Amrapali Capital and Finance Services Ltd

All Competitor Stocks of Amrapali Capital and Finance Services Ltd

Quarterly Result

Last Updated: July 16, 2025, 2:55 pm

Below is a detailed analysis of the quarterly data for Amrapali Capital and Finance Services Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 46.57 Cr.. The value appears strong and on an upward trend. It has increased from -2.37 Cr. (Sep 2024) to 46.57 Cr., marking an increase of 48.94 Cr..
• For Expenses, as of Mar 2025, the value is 46.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -2.17 Cr. (Sep 2024) to 46.41 Cr., marking an increase of 48.58 Cr..
• For Operating Profit, as of Mar 2025, the value is 0.16 Cr.. The value appears strong and on an upward trend. It has increased from -0.20 Cr. (Sep 2024) to 0.16 Cr., marking an increase of 0.36 Cr..
• For OPM %, as of Mar 2025, the value is 0.34%. The value appears strong and on an upward trend. It has increased from 0.00% (Sep 2024) to 0.34%, marking an increase of 0.34%.
• For Other Income, as of Mar 2025, the value is 2.49 Cr.. The value appears strong and on an upward trend. It has increased from 1.55 Cr. (Sep 2024) to 2.49 Cr., marking an increase of 0.94 Cr..
• For Interest, as of Mar 2025, the value is 0.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.91 Cr. (Sep 2024) to 0.14 Cr., marking a decrease of 0.77 Cr..
• For Depreciation, as of Mar 2025, the value is 1.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.27 Cr. (Sep 2024) to 1.55 Cr., marking an increase of 1.28 Cr..
• For Profit before tax, as of Mar 2025, the value is 0.96 Cr.. The value appears strong and on an upward trend. It has increased from 0.17 Cr. (Sep 2024) to 0.96 Cr., marking an increase of 0.79 Cr..
• For Tax %, as of Mar 2025, the value is -6.25%. The value appears to be improving (decreasing) as expected. It has decreased from 23.53% (Sep 2024) to -6.25%, marking a decrease of 29.78%.
• For Net Profit, as of Mar 2025, the value is 1.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Sep 2024) to 1.03 Cr., marking an increase of 0.90 Cr..
• For EPS in Rs, as of Mar 2025, the value is 1.05. The value appears strong and on an upward trend. It has increased from 0.13 (Sep 2024) to 1.05, marking an increase of 0.92.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:00 pm

Growth

Last Updated: September 5, 2025, 2:16 pm

Balance Sheet

Last Updated: September 10, 2025, 3:00 pm

Below is a detailed analysis of the balance sheet data for Amrapali Capital and Finance Services Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 9.78 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.78 Cr..
• For Reserves, as of Mar 2025, the value is 74.08 Cr.. The value appears strong and on an upward trend. It has increased from 72.93 Cr. (Mar 2024) to 74.08 Cr., marking an increase of 1.15 Cr..
• For Borrowings, as of Mar 2025, the value is 22.06 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 26.87 Cr. (Mar 2024) to 22.06 Cr., marking a decrease of 4.81 Cr..
• For Other Liabilities, as of Mar 2025, the value is 3.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.96 Cr. (Mar 2024) to 3.11 Cr., marking an increase of 1.15 Cr..
• For Total Liabilities, as of Mar 2025, the value is 109.03 Cr.. The value appears to be improving (decreasing). It has decreased from 111.54 Cr. (Mar 2024) to 109.03 Cr., marking a decrease of 2.51 Cr..
• For Fixed Assets, as of Mar 2025, the value is 4.23 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.23 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.07 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.07 Cr..
• For Other Assets, as of Mar 2025, the value is 104.73 Cr.. The value appears to be declining and may need further review. It has decreased from 107.24 Cr. (Mar 2024) to 104.73 Cr., marking a decrease of 2.51 Cr..
• For Total Assets, as of Mar 2025, the value is 109.03 Cr.. The value appears to be declining and may need further review. It has decreased from 111.54 Cr. (Mar 2024) to 109.03 Cr., marking a decrease of 2.51 Cr..

Notably, the Reserves (74.08 Cr.) exceed the Borrowings (22.06 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Amrapali Capital and Finance Services Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 5. It has increased from 0.96 (Mar 24) to 1.18, marking an increase of 0.22.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 5. It has increased from 0.96 (Mar 24) to 1.18, marking an increase of 0.22.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 3. It has increased from 1.54 (Mar 24) to 1.60, marking an increase of 0.06.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 85.76. It has increased from 84.58 (Mar 24) to 85.76, marking an increase of 1.18.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 85.76. It has increased from 84.58 (Mar 24) to 85.76, marking an increase of 1.18.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 45.20. It has decreased from 68.98 (Mar 24) to 45.20, marking a decrease of 23.78.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 4.08. This value is within the healthy range. It has increased from 3.52 (Mar 24) to 4.08, marking an increase of 0.56.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.66. This value is within the healthy range. It has increased from 2.93 (Mar 24) to 3.66, marking an increase of 0.73.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.15. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.15.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 2. It has increased from 0.95 (Mar 24) to 1.18, marking an increase of 0.23.
• For PBDIT Margin (%), as of Mar 25, the value is 9.02. This value is below the healthy minimum of 10. It has increased from 5.10 (Mar 24) to 9.02, marking an increase of 3.92.
• For PBIT Margin (%), as of Mar 25, the value is 8.09. This value is below the healthy minimum of 10. It has increased from 4.25 (Mar 24) to 8.09, marking an increase of 3.84.
• For PBT Margin (%), as of Mar 25, the value is 2.54. This value is below the healthy minimum of 10. It has increased from 1.66 (Mar 24) to 2.54, marking an increase of 0.88.
• For Net Profit Margin (%), as of Mar 25, the value is 2.60. This value is below the healthy minimum of 5. It has increased from 1.38 (Mar 24) to 2.60, marking an increase of 1.22.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 15. It has increased from 1.13 (Mar 24) to 1.37, marking an increase of 0.24.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.22. This value is below the healthy minimum of 10. It has increased from 3.39 (Mar 24) to 4.22, marking an increase of 0.83.
• For Return On Assets (%), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 5. It has increased from 0.83 (Mar 24) to 1.05, marking an increase of 0.22.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has decreased from 0.32 (Mar 24) to 0.26, marking a decrease of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has decreased from 0.64 (Mar 24) to 0.40, marking a decrease of 0.24.
• For Current Ratio (X), as of Mar 25, the value is 2.32. This value is within the healthy range. It has decreased from 2.53 (Mar 24) to 2.32, marking a decrease of 0.21.
• For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.52 (Mar 24) to 0.57, marking an increase of 0.05.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.62. This value is below the healthy minimum of 3. It has decreased from 1.98 (Mar 24) to 1.62, marking a decrease of 0.36.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 3. It has decreased from 1.54 (Mar 24) to 1.47, marking a decrease of 0.07.
• For Enterprise Value (Cr.), as of Mar 25, the value is 32.28. It has decreased from 37.37 (Mar 24) to 32.28, marking a decrease of 5.09.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.73, marking an increase of 0.18.
• For EV / EBITDA (X), as of Mar 25, the value is 8.09. This value is within the healthy range. It has decreased from 10.85 (Mar 24) to 8.09, marking a decrease of 2.76.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 24) to 0.40, marking an increase of 0.14.
• For Price / BV (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 24) to 0.40, marking an increase of 0.14.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.06, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness